<p>Tonsils from one HIV-1+individual under cART (MA35) tested positive for HIV p24Gag in the germinative center of tonsil (panel A, OM 10x), and expressed both uPAR and c-uPAR (panel B; seven tonsils from uninfected individuals (#36–46) were used as reference control). Sections used for Western blotting were from snap-frozen tissue blocks, whereas lysates from stably transfected HEK cells expressing uPAR and c-uPAR were used as positive controls; because of high levels of expression of these antigens in HEK cells actin was not detected at exposure time used for showing actin from tissue lysate. Chemotaxis of (panel C) and HIV expression from (panel D) U1 cells were measured as described in <a href="http://www.plosone.org/article/info:doi/10...
<p>HIV-1<sub>SF33</sub> was added to the AP surface of polarized tonsil (A), cervical (B) and foresk...
<p>LX2 cells were treated with virus-free culture supernatants from HIV-1 infected (R5- or X4- tropi...
We have described that either urokinase-type plasminogen activator (uPA) inhibits HIV expression in ...
<p>Tonsil blocks were left either uninfected (Nil) or were infected with R5 or X4 HIV-1 strain. Ever...
<p>Chemotaxis of chronically infected monocytic cells was tested (n = 3) in response to: A. tonsil c...
<p>(A) Polarized tonsil cells were transfected with control siRNA or siRNAs against Hrs and rabankyr...
Abstract: Mucosal associated lymphoid tissues are major targets of HIV during early infection and di...
<div><p>Cell-associated receptor for urokinase plasminogen activator (uPAR) is released as both full...
<p>(A) Activated and nonactivated PBMC were added to the AP surface of polarized tonsil epithelial c...
Cell-associated receptor for urokinase plasminogen activator (uPAR) is released as both full-length ...
<p>Figures are representative of tonsils and lymph nodes from uninfected and HIV-1<sup>+</sup> indiv...
<p>Tonsils from either uninfected (panels A-C) or HIV-1<sup>+</sup> individuals (panels D-F) showed ...
<p>(A) PHA-stimulated PBMCs were infected with adjusted amounts of the indicated viruses. Virus repl...
<div><p>(A) Expression of CD20 and DC-SIGN or CD23 and DC-SIGN in fresh (time 0 h; T0) and IL-4– and...
<p>(A) Polarized tonsil epithelial cells containing HIV-1<sub>SF33</sub> for 6 days were treated wit...
<p>HIV-1<sub>SF33</sub> was added to the AP surface of polarized tonsil (A), cervical (B) and foresk...
<p>LX2 cells were treated with virus-free culture supernatants from HIV-1 infected (R5- or X4- tropi...
We have described that either urokinase-type plasminogen activator (uPA) inhibits HIV expression in ...
<p>Tonsil blocks were left either uninfected (Nil) or were infected with R5 or X4 HIV-1 strain. Ever...
<p>Chemotaxis of chronically infected monocytic cells was tested (n = 3) in response to: A. tonsil c...
<p>(A) Polarized tonsil cells were transfected with control siRNA or siRNAs against Hrs and rabankyr...
Abstract: Mucosal associated lymphoid tissues are major targets of HIV during early infection and di...
<div><p>Cell-associated receptor for urokinase plasminogen activator (uPAR) is released as both full...
<p>(A) Activated and nonactivated PBMC were added to the AP surface of polarized tonsil epithelial c...
Cell-associated receptor for urokinase plasminogen activator (uPAR) is released as both full-length ...
<p>Figures are representative of tonsils and lymph nodes from uninfected and HIV-1<sup>+</sup> indiv...
<p>Tonsils from either uninfected (panels A-C) or HIV-1<sup>+</sup> individuals (panels D-F) showed ...
<p>(A) PHA-stimulated PBMCs were infected with adjusted amounts of the indicated viruses. Virus repl...
<div><p>(A) Expression of CD20 and DC-SIGN or CD23 and DC-SIGN in fresh (time 0 h; T0) and IL-4– and...
<p>(A) Polarized tonsil epithelial cells containing HIV-1<sub>SF33</sub> for 6 days were treated wit...
<p>HIV-1<sub>SF33</sub> was added to the AP surface of polarized tonsil (A), cervical (B) and foresk...
<p>LX2 cells were treated with virus-free culture supernatants from HIV-1 infected (R5- or X4- tropi...
We have described that either urokinase-type plasminogen activator (uPA) inhibits HIV expression in ...